Is the combination of neutrophil to lymphocyte and platelet to lymphocyte ratios a useful predictor of treatment response and prognosis in patients with non-small cell lung cancer?

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 10, 2014, Pages 4373-

  Tanoglu, Alpaslan ^a   Yiyit, Nurettin ^a   Berber, Ufuk ^a   Karagoz, Ergenekon ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; FEMALE; HUMAN; LUNG TUMOR; LYMPHOCYTE; MALE; NEUTROPHIL; NON SMALL CELL LUNG CANCER; PATHOLOGY; THROMBOCYTE;

BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; NEUTROPHILS;

EID: 84903515819     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.10.4373     Document Type: Letter

References (7)

1. Smith RA, Ghaneh P, Sutton R, et al (2008).Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1422-8.
2. Stotz M, Gerger A, Eisner F, et al (2013). Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21.
3. Tanoglu A, Karagoz E, Yiyit N, Berber U (2014). Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? Onco Targets Ther, 7, 433-4.
4. Tanoglu A, Karagoz E (2014). Predictive role of neutrophil to lymphocyte ratio in patients with advanced hepatocelluler carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 15, 1063.
5. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A. (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.
6. Wang D, Yang JX, Cao DY, et al (2013). Preoperative neutrophillymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. OncoTargets Ther, 6, 211-6.
7. Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31.